Unexpected Responses to Anti-VEGF Therapy in Eye Patients
Author Information
Author(s): Gilead Noa, Chong Yu Jeat, Ibrahim Farah N. I., Sun Christopher, Teo Kelvin Y. C., Cheung Chui Ming Gemmy
Primary Institution: Singapore Eye Research Institute, Singapore National Eye Centre
Hypothesis
How do different fluid compartments in the eye respond to faricimab treatment in patients with polypoidal choroidal vasculopathy?
Conclusion
The study found that while retinal fluid decreased in some areas, other areas showed unexpected increases in fluid after treatment.
Supporting Evidence
- All patients showed a reduction in subretinal fluid after treatment.
- Three patients had a gradual decrease in retinal pigment epithelium elevation over time.
- One patient completely resolved their retinal pigment epithelium elevation.
Takeaway
Doctors treated four patients' eye problems with a new medicine, and while some fluid got better, other fluid got worse, which was surprising.
Methodology
This case series describes the treatment responses of four patients with polypoidal choroidal vasculopathy to faricimab therapy.
Limitations
The study is limited by its small sample size and the observational nature of the case series.
Participant Demographics
Two males and two females, aged between 65 and 73 years, with no history of hypertension or diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website